Short ReportsTestosterone Therapy for Dropped Head Syndrome: A Case ReportFelong, Timothy J. BS*; Balos, Lucia L. MD†; Silvestri, Nicholas J. MD* Author Information Departments of *Neurology and †Pathology and Anatomical Sciences, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY. Reprints: Timothy J. Felong, BS, Department of Neurology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, 1010 Main Street, 2nd Floor, Buffalo, NY 14202 (e-mail: [email protected]). The authors report no conflicts of interest, and there are no sources of funding for this case report. Journal of Clinical Neuromuscular Disease: December 2022 - Volume 24 - Issue 2 - p 98-102 doi: 10.1097/CND.0000000000000372 Buy Metrics Abstract Dropped head syndrome (DHS) is an impairment of neck extension resulting in a chin-on-chest deformity. DHS is rarely seen but a major hindrance to daily function in affected patients. DHS has been associated with movement disorders, neuromuscular disorders, and electrolyte and endocrine abnormalities. DHS has also been seen in survivors of Hodgkin lymphoma (HL) years after irradiation. HL survivors are also at risk for endocrine hypogonadism after chemotherapy. We present the case of a 58-year-old male HL survivor with dropped head and limited strength in his atrophic neck extensor muscles. Laboratory testing and imaging, nerve conduction studies, electromyography, and muscle biopsy of the neck extensors revealed myopathic and neurogenic changes. Conservative management was unsuccessful. With a desire to avoid surgical fixation, he asked his primary care physician to check his testosterone levels, which returned as low normal. Within 4 months of starting testosterone therapy, he no longer experienced dropped head. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.